TABLE 2.
Summary of SWOG grade 3 or 4 toxicities at least possibly related to the study drug
| Age (yr) | Sexa | Underlying disease | Type of transplant/cells | Micafungin dose (mg) | Event | Day of onset | Duration of dosing (days) |
|---|---|---|---|---|---|---|---|
| 49 | F | Breast carcinoma | Autologous/peripheral stem cells | 50 | Atrial fibrillation | 7 | 6 |
| 37 | F | Breast carcinoma | Autologous/peripheral stem cells | 150 | Hypokalemia | 3 | 10 |
| 28 | F | CMLb | Allogeneic/cord blood cells | 200 | Pancreatitis | 30 | 27 |
| 54 | F | Breast carcinoma | Autologous/peripheral stem cells | 200 | Maculopapular rash | 8 | 10 |
a
F, female.
b
CML, chronic myelogenous leukemia.